Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)

Organon and Co2,904 enrolled

Overview

The purpose of this 6-week study is to compare the reduction in specific levels of cholesterol in patients with high cholesterol.

The duration of treatment is 6 weeks.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

2,904

Conditions

Hypercholesterolemia

Interventions

MK0653, ezetimibeDRUG

Comparator: statinsDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * High cholesterol levels that are identified by specific laboratory values Exclusion Criteria: * Active liver disease * Any condition or situation which would interfere with participation

Outcomes

Primary Outcomes

Percent change in LDL-C

Secondary Outcomes

Percentage of patients reaching NCEP ATP III target LDL-C levels

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.